Development of innovative antimicrobials against pathogens resistant to antimicrobials

This program funds activities that develop new antimicrobial products and candidate therapies to treat resistant bacteria and fungi, improving understanding and clinical options. It supports work that contributes to better treatment options and reduces the disease burden of antimicrobial resistance.

Amount: €8M — €10M
Type: Program

Key facts

Key facts for Development of innovative antimicrobials against pathogens resistant to antimicrobials
Amount	€8M — €10M — €44.2M shared across the programme
Issuer	Horizon Europe
Who can apply	See eligibility details
Sectors	HealthTech
Deadline	Closes 17 Feb 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: ec.europa.eu ↗

Source checked 11 hours ago

10 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Selection of hosting sites and fellows for EFSA's European Food Risk Assessment Fellowship (EU-FORA) Programme		Closes 24 Feb 2027
Call for proposals for operating grants in 2027 to non-governmental organisations: financial contribution to the functioning of health non-governmental organisations implementing one or more specific objectives of Regulation (EU) 2021/522 (OA-g-26-91 )		Closes 19 Jan 2027